Genzyme Fights Dismissal Of D&O Policy Suit

Law360, New York (October 29, 2009, 3:09 PM EDT) -- Genzyme Corp. is challenging the dismissal of its suit against Federal Insurance Co. that called for the insurer to pick up the tab for a securities class action the biotechnology company settled with investors two years ago.

Massachusetts-based Genzyme filed a notice of appeal to the U.S. Court of Appeals for the First Circuit on Wednesday, a month after the U.S. District Court for the District of Massachusetts granted Federal Insurance's motion to toss the case.

Genzyme alleged in its suit that a directors and officers...
To view the full article, register now.